Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated (UNH) provides extensive disclosure to investors and regulators through its SEC filings, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents offer a detailed view of the company’s health care and well-being operations, which span UnitedHealthcare’s health benefit programs and Optum’s health services, technology and analytics businesses.
Annual and quarterly reports describe UnitedHealth Group’s consolidated financial condition and results of operations, as well as segment performance for UnitedHealthcare and Optum. They include information on revenues, earnings from operations, medical costs, operating costs, cash flows, capital structure and risk factors. Investors use these filings to understand how trends in medical utilization, Medicare and Medicaid funding, and pharmacy services affect the company’s financial profile.
Current reports on Form 8-K provide timely updates on material events. Recent 8-K filings have covered topics such as quarterly earnings releases, reaffirmation of earnings outlooks, amendments to bylaws to reflect changes in the company’s registered office and registered agent in Delaware, the appointment of new independent directors, and investor presentations. Some 8-K items are furnished under Regulation FD to share information discussed with investors and analysts, including earnings expectations and the impact of acquisitions like Amedisys.
UnitedHealth Group also files 8-Ks to document governance and leadership changes, including the appointment of directors with regulatory and clinical backgrounds. These filings often reference standard indemnification agreements and compensation arrangements for non-employee directors, providing additional transparency into board practices.
On this SEC filings page, users can review UnitedHealth Group’s regulatory disclosures in one place. Real-time updates from EDGAR ensure that new 10-K, 10-Q and 8-K filings, as well as any amendments, appear promptly. AI-powered summaries can help explain complex sections, highlight key metrics, and clarify the implications of items such as changes in outlook, medical cost trends or bylaw amendments. Investors can also monitor executive and director changes reported on Form 8-K and use the filings history to track how UnitedHealth Group’s strategy, capital management and risk profile evolve over time.
UnitedHealth Group executive Erin McSweeney reported two insider transactions involving company common stock. On February 20, 2026, she disposed of 136.641 shares and 155.182 shares at $290.00 per share, both coded as F transactions, meaning shares were withheld to cover tax liabilities rather than sold on the open market.
UnitedHealth Group executive Christopher R. Zaetta reported two tax-related share dispositions. On February 20, 2026, he surrendered 130.851 and 312.436 shares of UnitedHealth common stock at a stated value of $290 per share to cover taxes by delivering shares rather than paying cash.
After these withholding transactions, his directly held balances reported in the filing were 9,984.430 shares following the first disposition and 9,671.994 shares following the second, reflecting routine administrative adjustments tied to equity compensation.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported two Form 4 transactions involving common stock. On February 20, 2026, he disposed of 249.6400 and 254.9080 shares at $290.00 per share as tax-withholding dispositions, meaning shares were withheld to cover tax obligations rather than sold on the open market. After these transactions, his directly owned common stock holdings were reported at 9,803.9580 shares.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported tax-related share dispositions under a Form 4. On February 20, 2026, he used 152.599 and 311.958 shares of common stock, each at $290.00 per share, to cover tax obligations. After these non-market transactions, he directly owned 8,740.495 common shares.
UnitedHealth Group Chief Accounting Officer Thomas E. Roos reported two tax-withholding share dispositions tied to equity compensation. On February 20, 2026, he surrendered a total of 326.067 shares of common stock in transactions coded “F” at
ROOS THOMAS E reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 322 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 29,325 shares.
Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 213 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 10,115 shares.
McSweeney Erin reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 153 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 11,040 shares.
UnitedHealth Group Chief Executive Officer, UHC, Timothy John Noel reported a tax-related share disposition under a Form 4. On 02/13/2026, 125.616 shares of UnitedHealth Group common stock were used to cover tax withholding at a price of $293.19 per share. Following this tax-withholding disposition, he directly owned 9,205.052 shares of common stock.
UnitedHealth Group executive Patrick H. Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On February 13, 2026, a Form 4 shows a code F tax-withholding disposition of 295.409 shares of UnitedHealth Group common stock at $293.19 per share. After this transaction, Conway directly beneficially owned 10,308.506 shares of common stock.